The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Affiliation
Hôpital Universitaire Robert Debré / AP-HP.Nord / Assistance Publique - Hôpitaux de Paris
Country
France
Current position
Dr. Thomas Storme is currently a hospital pharmacist at the Hôpital universitaire Robert Debré, in Paris, France. He is responsible for pharmaceutical compounding in this paediatric hospital. Dr. Storme is also a member of the Scientific Committee and of the Board of the
European Society of Hospital Pharmaceutical Technologies (GERPAC-ESHPT).
Education
Dr. Thomas Storme studied Pharmacy at the Université Paris-Descartes, France and became licensed pharmacist in 2006. In 2007, he obtained a PhD in medicinal chemistry at the same university for his work on the conception, synthesis and evaluation of new ifosfamide analogues designed to lower neurotoxic and nephrotoxic side-effects. After this academic work focused on medicinal chemistry and cancer care, Dr. Storme turned to hospital pharmacy in a Parisian paediatric hospital specialized in pharmaceutical technologies. As an external expert, he took part in the drafting of Good Compounding Practices published in 2022 by the French Drug Agency (ANSM).
Research area
Dr. Thomas Storme professional activity focuses on hospital drug production (sterile, especially personalised parenteral nutrition, and oral paediatric formulations (capsules, oral liquids). He is particularly interested in design and conception of production areas and utilities, in order to comply with applicable requirements. His priority is to keep it as simple and smart as possible for all users (physicians, nurses, pharmacy technicians, maintenance technicians, and of course, patients).
Conflict of interest
None